A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

IsraelRecruitingPHASE3

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Alabama Neurology Associates- Site Number : 8400019, Homewood, Alabama, United States

  • Honor Health Scottsdale Osborn Medical Center- Site Number : 8400014, Scottsdale, Arizona, United States

  • Keck School of Medicine of University of Southern California- Site Number : 8400002, Los Angeles, California, United States

  • University of California Irvine Medical Center- Site Number : 8400007, Orange, California, United States

  • Yale University School of Medicine- Site Number : 8400018, New Haven, Connecticut, United States

  • Nova Clinical Research - Bradenton- Site Number : 8400044, Bradenton, Florida, United States

  • AdventHealth Orlando- Site Number : 8400006, Orlando, Florida, United States

  • AdventHealth Site Number : 8400006, Orlando, Florida, United States

  • NorthShore University Health System - Glenbrook Hospital- Site Number : 8400024, Glenview, Illinois, United States

  • University of Kansas Medical Center- Site Number : 8400010, Kansas City, Kansas, United States

  • Ochsner Medical Center - Jefferson Highway- Site Number : 8400030, New Orleans, Louisiana, United States

  • Johns Hopkins Hospital- Site Number : 8400015, Baltimore, Maryland, United States

  • Massachusetts General Hospital- Site Number : 8400009, Boston, Massachusetts, United States

  • Henry Ford Hospital- Site Number : 8400025, Detroit, Michigan, United States

  • Michigan State University- Site Number : 8400038, East Lansing, Michigan, United States

  • Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037, St Louis, Missouri, United States

  • Profound Research- Site Number : 8400052, Las Vegas, Nevada, United States

  • Dent Neurologic Institute - Amherst- Site Number : 8400039, Amherst, New York, United States

  • Hospital for Special Surgery- Site Number : 8400041, New York, New York, United States

  • Columbia University Irving Medical Center- Site Number : 8400003, New York, New York, United States

  • Raleigh Neurology Associates- Site Number : 8400043, Raleigh, North Carolina, United States

  • University of Cincinnati Medical Center- Site Number : 8400020, Cincinnati, Ohio, United States

  • University Hospitals Cleveland Medical Center- Site Number : 8400033, Cleveland, Ohio, United States

  • Penn State Health Milton South Hershey Medical Center- Site Number : 8400042, Hershey, Pennsylvania, United States

  • Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022, Philadelphia, Pennsylvania, United States

  • Austin Neuromuscular Center- Site Number : 8400040, Austin, Texas, United States

  • UTHealth - The University of Texas Health Sciences Center at Houston- Site Number : 8400050, Houston, Texas, United States

  • University of Vermont Medical Center- Site Number : 8400012, Burlington, Vermont, United States

  • University of Virginia- Site Number : 8400023, Charlottesville, Virginia, United States

  • Investigational Site Number : 0320001, Buenos Aires, Argentina

  • Investigational Site Number : 0320002, Buenos Aires, Argentina

  • Investigational Site Number : 0320003, Buenos Aires, Argentina

  • Investigational Site Number : 0560002, Ghent, Belgium

  • Investigational Site Number : 0560001, Leuven, Belgium

  • L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760006, Brasília, Federal District, Brazil

  • Freire Pesquisa Clínica - Belo Horizonte - Rua Piauí- Site Number : 0760016, Belo Horizonte, Minas Gerais, Brazil

  • Instituto de Neurologia de Curitiba - Ecoville- Site Number : 0760007, Curitiba, Paraná, Brazil

  • InsCer - Instituto do Cérebro da PUCRS- Site Number : 0760002, Porto Alegre, Rio Grande do Sul, Brazil

  • PSEG Centro de Pesquisa Clínica- Site Number : 0760009, São Paulo, Brazil

  • Investigational Site Number : 1240003, London, Ontario, Canada

  • Investigational Site Number : 1240006, Montreal, Quebec, Canada

  • Investigational Site Number : 1240001, Québec, Quebec, Canada

  • Investigational Site Number : 1560013, Beijing, China

  • Investigational Site Number : 1560010, Beijing, China

  • Investigational Site Number : 1560005, Beijing, China

  • Investigational Site Number : 1560017, Beijing, China

  • Investigational Site Number : 1560009, Changsha, China

  • Investigational Site Number : 1560011, Chengdu, China

  • Investigational Site Number : 1560002, Fuzhou, China

  • Investigational Site Number : 1560012, Guangzhou, China

  • Investigational Site Number : 1560007, Guangzhou, China

  • Investigational Site Number : 1560014, Hangzhou, China

  • Investigational Site Number : 1560016, Jiazhuang, China

  • Investigational Site Number : 1560008, Jinan, China

  • Investigational Site Number : 1560015, Nanchang, China

  • Investigational Site Number : 1560001, Shanghai, China

  • Investigational Site Number : 1560003, Wuhan, China

  • Investigational Site Number : 1560006, Wuhan, China

  • Investigational Site Number : 1560004, Xi'an, China

  • Investigational Site Number : 2030004, Brno, Czechia

  • Investigational Site Number : 2030003, Hradec Králové, Czechia

  • Investigational Site Number : 2030005, Ostrava, Czechia

  • Investigational Site Number : 2030002, Pardubice, Czechia

  • Investigational Site Number : 2030001, Prague, Czechia

  • Investigational Site Number : 2080002, Aarhus, Denmark

  • Investigational Site Number : 2080001, Copenhagen, Denmark

  • Investigational Site Number : 2500001, Le Kremlin-Bicêtre, France

  • Investigational Site Number : 2500002, Marseille, France

  • Investigational Site Number : 2500005, Nice, France

  • Investigational Site Number : 2500003, Paris, France

  • Investigational Site Number : 2760003, Berlin, Germany

  • Investigational Site Number : 2760008, Bochum, Germany

  • Investigational Site Number : 2760007, Essen, Germany

  • Investigational Site Number : 2760006, Göttingen, Germany

  • Investigational Site Number : 2760005, Hanover, Germany

  • Investigational Site Number : 2760001, Münster, Germany

  • Investigational Site Number : 3480003, Budapest, Hungary

  • Investigational Site Number : 3480005, Budapest, Hungary

  • Investigational Site Number : 3480004, Győr, Hungary

  • Investigational Site Number : 3480001, Szeged, Hungary

  • Investigational Site Number : 3760001, Haifa, Israel

  • Investigational Site Number : 3800004, Milan, Milano, Italy

    Contact: Study coordinator (Yuri Falzone) · falzone.yuri@hsr.it · 003902264321312
    Contact: Principal Investigator (Stefano Previtali)
  • Investigational Site Number : 3800001, Padua, Padova, Italy

    Contact: Study coordinator (Alessandro Salvalaggio) · alessandro.salvalaggio@unipd.it
  • Investigational Site Number : 3800002, Bologna, Italy

  • Investigational Site Number : 3920007, Amagasaki, Hyōgo, Japan

  • Investigational Site Number : 3920015, Yokohama, Kanagawa, Japan

  • Investigational Site Number : 3920012, Higashi-Matsuyama, Saitama, Japan

  • Investigational Site Number : 3920005, Kawagoe, Saitama, Japan

  • Investigational Site Number : 3920014, Yaizu, Shizuoka, Japan

  • Investigational Site Number : 3920008, Kodaira, Tokyo, Japan

  • Investigational Site Number : 3920010, Ōta-ku, Tokyo, Japan

  • Investigational Site Number : 3920001, Chiba, Japan

  • Investigational Site Number : 3920009, Saga, Japan

  • Investigational Site Number : 4840002, Chihuahua City, Mexico

  • Investigational Site Number : 4840001, Tlalnepantla, Mexico

  • Investigational Site Number : 5780001, Oslo, Norway

  • Investigational Site Number : 6200003, Braga, Portugal

  • Investigational Site Number : 6200005, Coimbra, Portugal

  • Investigational Site Number : 6200002, Lisbon, Portugal

  • Investigational Site Number : 6200001, Lisbon, Portugal

  • Investigational Site Number : 7240012, Santiago de Compostela, A Coruña [La Coruña], Spain

  • Investigational Site Number : 7240009, Barcelona, Barcelona [Barcelona], Spain

  • Investigational Site Number : 7240006, Sabadell, Barcelona [Barcelona], Spain

  • Investigational Site Number : 7240001, Barcelona, Catalunya [Cataluña], Spain

  • Investigational Site Number : 7240008, Majadahonda, Madrid, Spain

  • Investigational Site Number : 7240002, Pamplona, Navarre, Spain

  • Investigational Site Number : 7240003, Oviedo, Principality of Asturias, Spain

  • Investigational Site Number : 7240007, Málaga, Spain

  • Investigational Site Number : 7240010, Santa Cruz de Tenerife, Spain

  • Investigational Site Number : 7240004, Valencia, Spain

  • Investigational Site Number : 7520001, Stockholm, Sweden

  • Investigational Site Number : 7560001, Basel, Switzerland

  • Investigational Site Number : 7560003, Bern, Switzerland

  • Investigational Site Number : 1580003, Kaohsiung City, Taiwan

  • Investigational Site Number : 1580001, Taipei, Taiwan

  • Investigational Site Number : 1580002, Taipei, Taiwan

  • Investigational Site Number : 7920004, Bursa, Turkey (Türkiye)

  • Investigational Site Number : 7920001, Istanbul, Turkey (Türkiye)

  • Investigational Site Number : 7920002, Istanbul, Turkey (Türkiye)

  • Investigational Site Number : 7920003, Konya, Turkey (Türkiye)

  • Investigational Site Number : 8260007, London, England, United Kingdom

  • Investigational Site Number : 8260003, Inverness, Highland, United Kingdom

  • Investigational Site Number : 8260001, Oxford, Oxfordshire, United Kingdom